Differential effects of nicotine and aging on splenocyte proliferation and the production of Th1-versus Th2-type cytokines

被引:30
作者
Hallquist, N
Hakki, A
Wecker, L
Friedman, H
Pross, S
机构
[1] Univ S Florida, Coll Med, Dept Med Microbiol & Immunol, Tampa, FL 33612 USA
[2] Univ S Florida, Coll Med, Dept Pharmacol & Therapeut, Tampa, FL 33612 USA
来源
PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE | 2000年 / 224卷 / 03期
关键词
D O I
10.1046/j.1525-1373.2000.22412.x
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Nicotine has a multitude of biological actions in the central and peripheral nervous systems where nicotinic acetylcholine receptors are found. Nicotinic acetylcholine receptors have also been identified on immune cells, but the effects of nicotine on immune responses are not well characterized. These studies tested the hypotheses that nicotine has an effect on both T-lymphocyte proliferation and the production of cytokines by activated T cells, processes that are necessary for effective T-cell-mediated immune responses. In addition, the effects of nicotine on these immune responses in aging animals and the effects of nicotine exposure prior to immunostimulation were investigated. Murine splenocytes were exposed to nicotine and stimulated with concanavalin A (ConA). The highest concentration of nicotine (128 mu g/ml) significantly depressed proliferation of T cells both when nicotine and ConA were added concurrently and when nicotine was added 3 hr prior to ConA. Nicotine, added concurrently with ConA at concentrations between 0.25 and 64 mu g/ml, significantly inhibited the production of IL-10 by splenocytes from young adult mice, whereas the inhibition of production of IL-10 by splenocytes from old mice was significantly inhibited, but the response was more variable, depending on the nicotine concentration. In contrast, the production of IFN-gamma by splenocytes from either young adult or old mice was not affected when nicotine (0.016-64 mu g/ml) was added concurrently with ConA. Pre-exposure to 1 mu g/ml of nicotine for 3 hr significantly enhanced the production of IFN-gamma by splenocytes from young adult mice, whereas pre-exposure to 0.016 mu g/ml of nicotine tended to but did not significantly enhance IFN-gamma production. Nicotine is now being used as an over-the-counter drug by people who differ in age and general immunocompetence. Therefore, the effects of nicotine on immune responses, independent from the effects of the other chemicals found in tobacco, need to be investigated.
引用
收藏
页码:141 / 146
页数:6
相关论文
共 41 条
[1]   EXTRANEURAL CHOLINERGIC MARKERS IN ALZHEIMERS AND PARKINSONS-DISEASE [J].
ADEM, A ;
NORDBERG, A ;
BUCHT, G ;
WINBLAD, B .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1986, 10 (3-5) :247-257
[2]   Beneficial effects of nicotine and cigarette smoking: The real, the possible and the spurious [J].
Baron, JA .
BRITISH MEDICAL BULLETIN, 1996, 52 (01) :58-73
[3]   Pharmacology of nicotine: Addiction and therapeutics [J].
Benowitz, NL .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1996, 36 :597-613
[4]   Respiratory symptoms and pulmonary function in an elderly nonsmoking population [J].
Berglund, DJ ;
Abbey, DE ;
Lebowitz, MD ;
Knutsen, SF ;
McDonnell, WF .
CHEST, 1999, 115 (01) :49-59
[5]  
BHANDARI N, 1996, SOURCE BOOK SUBSTANC, P140
[6]   Cytokine production by subsets of CD4 memory T cells differing in P-glycoprotein expression: Effects of aging [J].
Bining, N ;
Miller, RA .
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 1997, 52 (03) :B137-B145
[7]   EVIDENCE FOR A NON-CHOLINERGIC NICOTINE RECEPTOR ON HUMAN PHAGOCYTIC LEUKOCYTES [J].
DAVIES, BD ;
HOSS, W ;
LIN, JP ;
LIONETTI, F .
MOLECULAR AND CELLULAR BIOCHEMISTRY, 1982, 44 (01) :23-31
[8]   Risk factors for allergy [J].
De Swert, LFA .
EUROPEAN JOURNAL OF PEDIATRICS, 1999, 158 (02) :89-94
[9]   Effects of nicotine on the immune response .1. Chronic exposure to nicotine impairs antigen receptor-mediated signal transduction in lymphocytes [J].
Geng, YM ;
Savage, SM ;
Johnson, LJ ;
Seagrave, J ;
Sopori, ML .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1995, 135 (02) :268-278
[10]   Tobacco and cancer: Approaches using carcinogen biomarkers and chemoprevention [J].
Hecht, SS .
CANCER: GENETICS AND THE ENVIRONMENT, 1997, 833 :91-111